Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06759298
EARLY_PHASE1

The Effects of Methylphenidate on Symptomatology in Individuals With Borderline Personality Disorder

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

This study aims to investigate the effects of methylphenidate on symptomatology in individuals with borderline personality disorder. Specifically, it will evaluate whether Concerta is effective in reducing impulsivity, mood instability, and inattention among patients with BPD. Additionally, the study will assess Concerta's safety profile in this population to determine its potential as a supportive pharmacological option in BPD management.

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-01-15

Completion Date

2025-03-25

Last Updated

2025-01-06

Healthy Volunteers

Yes

Interventions

DRUG

methylphenidate

patient group will recieve methylphenidate

DRUG

matched placebo tablet

placebo gtoup will recieve matched placebo tablet